The policy authorizes sharing of personal and health information with pharmacies, laboratories, and affiliated healthcare entities involved in delivering Ro's telehealth services.
This analysis describes what Ro's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision establishes the categories of third-party healthcare entities that may receive patient health information through Ro's platform, which is operationally significant for determining which downstream entities handle protected health information and whether appropriate BAAs or data sharing agreements are in place.
Interpretive note: The policy does not enumerate specific pharmacy or laboratory partners, and the scope of sharing with Ro-affiliated entities is not precisely defined, creating uncertainty about which entities receive health data and under what legal basis.
Under this provision, health information provided through Ro's platform may be shared with pharmacies, laboratories, and affiliated healthcare providers as part of delivering telehealth services. The agreement establishes these disclosures as inherent to the service delivery model rather than optional.
Cross-platform context
See how other platforms handle Health Information Sharing with Pharmacies and Affiliated Providers and similar clauses.
Compare across platforms →Monitoring
Ro has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"We may share your personal information, including health information, with pharmacies, laboratory providers, and other healthcare providers involved in your care, as well as with Ro-affiliated entities that provide services in connection with your use of the platform.— Excerpt from Ro's Ro Privacy Policy
REGULATORY LANDSCAPE: Sharing of PHI with pharmacies and laboratories as part of treatment delivery is a HIPAA-permitted activity under the treatment, payment, and healthcare operations (TPO) exception. HHS OCR is the primary enforcement authority. However, the policy's reference to sharing with Ro-affiliated entities may encompass non-HIPAA-covered technology or operational entities, which would require separate legal justification under state privacy statutes. GOVERNANCE EXPOSURE: Medium. The policy does not enumerate specific pharmacy or laboratory partners, making it difficult for compliance teams to assess which entities receive health data and whether appropriate contractual protections are in place. The reference to Ro-affiliated entities requires mapping to determine which affiliates are HIPAA-covered and which are not. JURISDICTION FLAGS: All US jurisdictions are relevant given HIPAA's federal scope. State pharmacy privacy statutes and laboratory data laws may impose additional obligations in specific states. Washington's My Health MY Data Act may apply to health data shared with non-HIPAA-covered affiliated entities. CONTRACT AND VENDOR IMPLICATIONS: BAAs should be in place with all pharmacy and laboratory partners that receive PHI. Contracts with Ro-affiliated entities that receive health information should specify permitted uses and data protection obligations consistent with applicable law. COMPLIANCE CONSIDERATIONS: Compliance teams should maintain a current inventory of pharmacy and laboratory partners receiving patient health information and verify that BAAs are executed and current. The scope of sharing with Ro-affiliated entities should be documented and reviewed against HIPAA minimum necessary standards and applicable state health data statutes.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 3 platforms + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision establishes the categories of third-party healthcare entities that may receive patient health information through Ro's platform, which is operationally significant for determining which downstream entities handle protected health information and whether appropriate BAAs or data sharing agreements are in place.
Under this provision, health information provided through Ro's platform may be shared with pharmacies, laboratories, and affiliated healthcare providers as part of delivering telehealth services. The agreement establishes these disclosures as inherent to the service delivery model rather than optional.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Ro.